SS4-89180-47219
2 vaccinations
1 coded response
9 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 21-25
- ZIP prefix
- 293 / SC
- Registered
- 2021-09-15
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-08-04
Dose 1 — Pfizer-BioNTech
-
2021-09-05
Dose 2 — Pfizer-BioNTech
-
2021-09-15
Registered in v-safe
- 2021-09-15
- 2021-09-19
- 2021-09-26
- 2021-10-03
- 2021-10-10
- 2021-10-17
- 2021-12-07
-
2022-03-06
Survey response — 6 months, dose 2MedDRA: Postpartum disorder, Syncope — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · HospitalizationFree text: Postpartum syncopeMedDRA releases: 2024-11 · check-in free text available
-
2022-03-06
Report sent to call center — 6 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prHospitalization · 1 call case(s)
-
2022-03-08
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
- 2022-09-05
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-08-04 | Pfizer-BioNTech | No |
| 2 | 2021-09-05 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
Release 11 — 6 months, dose 2
Symptoms: Postpartum syncope
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Postpartum disorder | · | · | ✓ |
| SD | Syncope | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release